Proud to be a part of launching two high-impact studies at 23andMe over the past month! Learn more: Lung cancer is the leading cause of cancer death worldwide and relatively little is known about genetic risk factors. This study brings together over 20+ advocacy groups to help understand more about how genetics influence lung cancer. https://lnkd.in/gFxqmDy8 GLP-1 use is growing. We seek to gather real-world evidence to discover genetic predictors of treatment response and side effects. https://lnkd.in/gUbnDd9E
Today we’re announcing a new study to advance research on lung cancer. While lung cancer research and targeted therapies have provided hope and progress for many, this study aims to learn more about the genetics behind the disease and its causes. Learn more here: https://23and.me/3zVjzEm
Social Impact | Project Director | Operations Lead
6moMany congrats - this is important work, Vinh!